If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Regulatory News (FUTR)

Share Price Information for Future (FUTR)

Share Price is delayed by 15 minutes
Get Live Data
288.20    -2.00 (-0.69%)
Bid:
285.80
Ask:
286.60
Spread: 0.80 (0.28%)
Market Cap: £259.22m
FUTR Live PriceLast checked at - London Stock Exchange

Intraday Future Share Chart

Further re Rule 19.6(c) confirmation

17 Feb 2022 07:00

RNS Number : 9151B
Future PLC
17 February 2022
 

THE FOLLOWING ANNOUNCEMENT IS BEING MADE PURSUANT TO THE REQUIREMENTS OF RULE 19.6(C) OF THE TAKEOVER CODE (THE "CODE") WHICH, AMONGST OTHER THINGS, REQUIRES A PARTY TO AN OFFER TO MAKE AN ANNOUNCEMENT AT THE END OF THE PERIOD OF 12 MONTHS FROM THE END OF THE OFFER PERIOD CONFIRMING WHETHER IT HAS TAKEN, OR NOT TAKEN, THE COURSE OF ACTION SET OUT IN ITS STATED INTENTIONS.

 

For immediate release

 

17 February 2022

 

FUTURE plc

 

Rule 19.6(c) confirmation with respect to stated post-offer intentions for GoCo Group

 

Future plc ("Future") announces that, further to the completion of the recommended cash and share offer by Future for the entire issued and to be issued share capital of GoCo Group plc (the "Combination") which was implemented by a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 and became effective on 17 February 2021, Future has duly confirmed in writing to the Takeover Panel in accordance with the requirements of Rule 19.6(c) of the Code that Future has complied, subject to the matter disclosed in the following paragraph, with the post-offer intention statements made pursuant to Rules 2.7(c)(iv) and 24.2 of the Code, as originally detailed in its announcement of 25 November 2020 and the scheme document published on 14 December 2020.

 

In such announcement and scheme document Future stated its intention to retain Future's existing offices in London at Paddington and Canary Wharf. Following a review of working patterns after the lifting of Covid restrictions, a decision was made to consolidate Future's London premises in Paddington and, accordingly, the Canary Wharf office was closed in December 2021 with no impact on employee headcount.

 

Enquiries:

 

Future plc

 

+44 (0) 1225 442244

 

Zillah Byng-Thorne, Chief Executive Officer

Penny Ladkin-Brand, Chief Financial Officer

Marion Le Bot, Head of Investor Relations

+44 (0) 7775 641509

 

 

 

Numis Securities

 

+44 (0) 20 7260 1000

 

Nick Westlake, Mark Lander, Alec Pratt, Hugo Rubinstein

 

J.P. Morgan Cazenove

 

+44 (0) 20 7742 4000

 

Bill Hutchings, Matt Smith, Mose Adigun

 

Headland Consultancy

 

+44 (0) 20 3805 4822

 

Stephen Malthouse, Rob Walker, Charlie Twigg

 

future@headlandconsultancy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURKZGMZVVDGZZM
Date   Source Headline
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 202611:12 amRNSHolding(s) in Company
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20264:10 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 202610:45 amRNSDirector/PDMR Shareholding
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20265:21 pmRNSHolding(s) in Company
5th Feb 20264:42 pmRNSResult of AGM
5th Feb 202612:45 pmRNSDirector/PDMR Shareholding
5th Feb 20267:00 amRNSTrading Update
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20269:36 amRNSTotal Voting Rights
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSAcquisition of SheerLuxe
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20268:18 amRNSHolding(s) in Company
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.